Cite
MLA Citation
S.J. Blakemore et al.. “PRELIMINARY EVIDENCE OF A MOLECULAR PREDICTOR OF TAZEMETOSTAT RESPONSE, BEYOND EZH2 MUTATION, IN NHL PATIENTS VIA CHARACTERIZATION OF ARCHIVE TUMOR AND CIRCULATING TUMOR DNA.” Hematological oncology, vol. 35, n.d., pp. 159–160. http://access.bl.uk/ark:/81055/vdc_100047429737.0x000030